The mortality rate for trachea, bronchus, or lung malignant neoplasms in Brazil is projected to remain stable from 2024 to 2028, hovering around 22.8 to 22.9 deaths per hundred thousand persons. Comparatively, this rate was consistent in 2023, maintaining the forecasted trend for 2024 onwards. The year-on-year variation between 2024 through 2028 is a mere 0.44%, highlighting a minimal increase annually. The compound annual growth rate (CAGR) over the five years remains negligible, showing a stable mortality pattern.
Future trends to monitor include advancements in medical treatments and public health initiatives aimed at reducing smoking prevalence, as these factors could significantly impact mortality rates linked to these diseases, potentially leading to a downward trend beyond 2028.
